Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression

Kidney International

Volumn 91, Issue 1, 2017, Pages 196-203

  Hsu, Chi yuan ^a,b   Xie, Dawei ^c   Waikar, Sushrut S ^d   Bonventre, Joseph V ^d   Zhang, Xiaoming ^c   Sabbisetti, Venkata ^d   Mifflin, Theodore E ^c   Coresh, Josef ^e   Diamantidis, Clarissa J ^f   He, Jiang ^g,n   Lora, Claudia M ^h   Miller, Edgar R ^e   Nelson, Robert G ⁱ   Ojo, Akinlolu O ^j,n   Rahman, Mahboob ^k,n   Schelling, Jeffrey R ^k   Wilson, Francis P ^l   Kimmel, Paul L ⁱ   Feldman, Harold I ^c,n   Vasan, Ramachandran S ^m   Liu, Kathleen D ^a   Appel, Lawrence J ⁿ   Go, Alan S ⁿ   Kusek, John W ⁿ   Lash, James P ⁿ   Townsend, Raymond R ⁿ   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER PERMANENTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f DUKE UNIVERSITY   (United States)

^g TULANE UNIVERSITY   (United States)

^h UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

ⁱ NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^j UNIVERSITY OF MICHIGAN   (United States)

^k CASE WESTERN RESERVE UNIVERSITY   (United States)

^l YALE UNIVERSITY   (United States)

^m BOSTON UNIVERSITY   (United States)

ⁿ NONE

more..

Author keywords

chronic kidney disease; microalbuminuria; proteinuria

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CREATININE; FATTY ACID BINDING PROTEIN; KIDNEY INJURY MOLECULE 1; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACETYLGLUCOSAMINIDASE; FABP1 PROTEIN, HUMAN; HAVCR1 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CREATININE URINE LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HUMAN; INTERMEDIATE RISK POPULATION; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; AGED; ALBUMINURIA; FOLLOW UP; GLOMERULUS FILTRATION RATE; KIDNEY FAILURE, CHRONIC; KIDNEY TUBULE; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; URINE; VALIDATION STUDY;

ACETYLGLUCOSAMINIDASE; AGED; ALBUMINURIA; BIOMARKERS; CREATININE; DISEASE PROGRESSION; FATTY ACID-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEPATITIS A VIRUS CELLULAR RECEPTOR 1; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TUBULES; LIPOCALIN-2; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS;

EID: 85005965748     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.09.003     Document Type: Article

References (69)

1. 1 Fassett, R.G., Venuthurupalli, S.K., Gobe, G.C., et al. Biomarkers in chronic kidney disease: a review. Kidney Int 80 (2011), 806–821.
2. 2 Brosius, F.C., Pennathur, S., How to find a prognostic biomarker for progressive diabetic nephropathy. Kidney Int 83 (2013), 996–998.
3. 3 Merchant, M.L., Can the urinary peptidome outperform creatinine and albumin to predict renal function decline?. J Am Soc Nephrol 26 (2015), 1760–1761.
4. 4 Peralta, C.A., Katz, R., Bonventre, J.V., et al. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 60 (2012), 904–911.
5. 5 Liu, K.D., Yang, W., Anderson, A.H., et al. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease. Kidney Int 83 (2013), 909–914.
6. 6 Smith, E.R., Lee, D., Cai, M.M., et al. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD). Nephrol Dial Transplant 28 (2013), 1569–1579.
7. 7 Bolignano, D., Lacquaniti, A., Coppolino, G., et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 4 (2009), 337–344.
8. 8 Fufaa, G.D., Weil, E.J., Nelson, R.G., et al. Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus. Diabetologia 58 (2015), 188–198.
9. 9 Araki, S., Haneda, M., Koya, D., et al. Predictive effects of urinary liver-type fatty acid–binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy. Diabetes Care 36 (2013), 1248–1253.
10. 10 Kamijo-Ikemori, A., Sugaya, T., Yasuda, T., et al. Clinical significance of urinary liver-type fatty acid–binding protein in diabetic nephropathy of type 2 diabetic patients. Diabetes Care 34 (2011), 691–696.
11. 11 Nielsen, S.E., Sugaya, T., Hovind, P., et al. Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients. Diabetes Care 33 (2010), 1320–1324.
12. 12 Panduru, N.M., Forsblom, C., Saraheimo, M., et al. Urinary liver-type fatty acid–binding protein and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 36 (2013), 2077–2083.
13. 13 Nielsen, S.E., Andersen, S., Zdunek, D., et al. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Kidney Int 79 (2011), 1113–1118.
14. 14 Nielsen, S.E., Hansen, H.P., Jensen, B.R., et al. Urinary neutrophil gelatinase-associated lipocalin and progression of diabetic nephropathy in type 1 diabetic patients in a four-year follow-up study. Nephron Clin Pract 118 (2011), c130–c135.
15. 15 Bhavsar, N.A., Kottgen, A., Coresh, J., et al. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 60 (2012), 233–240.
16. 16 Lim, W.H., Lewis, J.R., Wong, G., et al. Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women. Am J Nephrol 41 (2015), 156–164.
17. 17 Looker, H.C., Colombo, M., Hess, S., et al. Biomarkers of rapid chronic kidney disease progression in type 2 diabetes. Kidney Int 88 (2015), 888–896.
18. 18 Hayek, S.S., Sever, S., Ko, Y.A., et al. Soluble urokinase receptor and chronic kidney disease. N Engl J Med 373 (2015), 1916–1925.
19. 19 Ju, W., Nair, V., Smith, S., et al. Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker. Sci Transl Med, 7, 2015, 316ra193.
20. 20 Liu, K.D., Yang, W., Hsu, C.Y., The value of urinary neutrophil gelatinase-associated lipocalin in risk prediction of renal decline in patients with chronic kidney disease. Kidney Int, 84, 2013, 217.
21. 21 Hsu, C.Y., Ballard, S., Batlle, D., et al. Cross-disciplinary biomarkers research: lessons learned by the CKD Biomarkers Consortium. Clin J Am Soc Nephrol 10 (2015), 894–902.
22. 22 Lin, H.Y.H., Hwang, D.Y., Lee, S.C., et al. Urinary neutrophil gelatinase-associated lipocalin and clinical outcomes in chronic kidney disease patients. Clin Chem Lab Med 53 (2015), 73–83.
23. 23 Foster, M.C., Coresh, J., Bonventre, J.V., et al. Urinary biomarkers and risk of ESRD in the Atherosclerosis Risk in Communities Study. Clin J Am Soc Nephrol 10 (2015), 1956–1963.
24. 24 Schanstra, J.P., Zurbig, P., Alkhalaf, A., et al. Diagnosis and prediction of CKD progression by assessment of urinary peptides. J Am Soc Nephrol 26 (2015), 1999–2010.
25. 25 Tangri, N., Kitsios, G.D., Inker, L.A., et al. Risk prediction models for patients with chronic kidney disease: a systematic review. Ann Intern Med 158 (2013), 596–603.
26. 26 Landray, M.J., Emberson, J.R., Blackwell, L., et al. Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study. Am J Kidney Dis 56 (2010), 1082–1094.
27. 27 Tangri, N., Stevens, L.A., Griffith, J., et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 305 (2011), 1553–1559.
28. 28 Tangri, N., Grams, M.E., Levey, A.S., et al. Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. JAMA 315 (2016), 164–174.
29. 29 Matsushita, K., Mahmoodi, B.K., Woodward, M., et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 307 (2012), 1941–1951.
30. 30 D'Agostino, R.B. Sr., Grundy, S., Sullivan, L.M., et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286 (2001), 180–187.
31. 31 Wang, T.J., Gona, P., Larson, M.G., et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355 (2006), 2631–2639.
32. 32 Peralta, C., Scherzer, R., Grunfeld, C., et al. Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS). HIV Med 15 (2014), 291–300.
33. 33 Tojo, A., Endou, H., Intrarenal handling of proteins in rats using fractional micropuncture technique. Am J Physiol 263 (1992), F601–F606.
34. 34 Sandoval, R.M., Wagner, M.C., Patel, M., et al. Multiple factors influence glomerular albumin permeability in rats. J Am Soc Nephrol 23 (2012), 447–457.
35. 35 Russo, L.M., Sandoval, R.M., McKee, M., et al. The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney Int 71 (2007), 504–513.
36. 36 Zoja, C., Donadelli, R., Colleoni, S., et al. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 53 (1998), 1608–1615.
37. 37 Wang, Y., Chen, J., Chen, L., et al. Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 8 (1997), 1537–1545.
38. 38 Drumm, K., Bauer, B., Freudinger, R., et al. Albumin induces NF-kappaB expression in human proximal tubule-derived cells (IHKE-1). Cell Physiol Biochem 12 (2002), 187–196.
39. 39 van Timmeren, M.M., Bakker, S.J., Vaidya, V.S., et al. Tubular kidney injury molecule-1 in protein-overload nephropathy. Am J Physiol Renal Physiol 291 (2006), F456–F464.
40. 40 Wagner, M.C., Campos-Bilderback, S.B., Chowdhury, M., et al. Proximal tubules have the capacity to regulate uptake of albumin. J Am Soc Nephrol 27 (2016), 382–494.
41. 41 Tenten, V., Menzel, S., Kunter, U., et al. Albumin is recycled from the primary urine by tubular transcytosis. J Am Soc Nephrol 24 (2013), 1966–1980.
42. 42 Dickson, L.E., Wagner, M.C., Sandoval, R.M., et al. The proximal tubule and albuminuria: really!. J Am Soc Nephrol 25 (2014), 443–453.
43. 43 Jarad, G., Miner, J.H., Albuminuria, wherefore art thou?. J Am Soc Nephrol 20 (2009), 455–457.
44. 44 Haraldsson, B., Nystrom, J., Deen, W.M., Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 88 (2008), 451–487.
45. 45 Niewczas, M.A., Gohda, T., Skupien, J., et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol 23 (2012), 507–515.
46. 46 Gohda, T., Niewczas, M.A., Ficociello, L.H., et al. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol 23 (2012), 516–524.
47. 47 Panduru, N.M., Sandholm, N., Forsblom, C., et al. Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes. Diabetes Care 38 (2015), 1130–1137.
48. 48 Brunner, H.I., Bennett, M.R., Mina, R., et al. Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum 64 (2012), 2687–2697.
49. 49 Zhang, X., Nagaraja, H.N., Nadasdy, T., et al. A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies. Kidney Int 81 (2012), 401–406.
50. 50 Liu, K.D., Yang, W., Go, A.S., et al. Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis 65 (2015), 267–274.
51. 51 Hsu, C.Y., Ordonez, J.D., Chertow, G.M., et al. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int 74 (2008), 101–107.
52. 52 Hsu, R.K., Hsu, C.Y., Proteinuria and reduced glomerular filtration rate as risk factors for acute kidney injury. Curr Opin Nephrol Hypertens 20 (2011), 211–217.
53. 53 Schuh, M.P., Nehus, E., Ma, Q., et al. Long-term stability of urinary biomarkers of acute kidney injury in children. Am J Kidney Dis 67 (2016), 56–61.
54. 54 van de Vrie, M., Deegens, J.K., van der Vlag, J., et al. Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL). Am J Kidney Dis 63 (2014), 573–576.
55. 55 Parikh, C.R., Butrymowicz, I., Yu, A., et al. Urine stability studies for novel biomarkers of acute kidney injury. Am J Kidney Dis 63 (2014), 567–572.
56. 56 Nauta, F.L., Bakker, S.J.L., Heerspink, H.L., et al. Effect of frozen storage on urinary concentration of kidney damage markers. Am J Kidney Dis 59 (2012), 586–589.
57. 57 Pennemans, V., Rigo, J.M., Penders, J., et al. Collection and storage requirements for urinary kidney injury molecule-1 (KIM-1) measurements in humans. Clin Chem Lab Med 50 (2012), 539–543.
58. 58 Bansal, N., Carpenter, M.A., Weiner, D.E., et al. Urine injury biomarkers and risk of adverse outcomes in recipients of prevalent kidney transplants: the Folic Acid for Vascular Outcome Reduction in Transplantation Trial. J Am Soc Nephrol 27 (2016), 2109–2121.
59. 59 Pontillo, C., Jacobs, L., Staessen, J.A., et al. A urinary proteome-based classifier for the early detection of decline in glomerular filtration. Nephrol Dial Transplant 31 (2016), 38–39.
60. 60 Feldman, H.I., Appel, L.J., Chertow, G.M., et al. The Chronic Renal Insufficiency Cohort (CRIC) study: design and methods. J Am Soc Nephrol 14 (2003), S148–S153.
61. 61 Lash, J.P., Go, A.S., Appel, L.J., et al. Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol 4 (2009), 1302–1311.
62. 62 Fischer, M.J., Go, A.S., Lora, C.M., et al. CKD in Hispanics: baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC Studies. Am J Kidney Dis 58 (2011), 214–227.
63. 63 Chronic Kidney Disease Biomarker Consortium: CKD Biomarker Consortium Laboratory SOPs. Available at: http://www.ckdbiomarkersconsortium.org/. Accessed July 29, 2016.
64. 64 Grenier, F.C., Ali, S., Syed, H., et al. Evaluation of the ARCHITECT urine NGAL assay: Assay performance, specimen handling requirements and biological variability. Clin Biochem 43 (2010), 615–620.
65. 65 Yang, W., Xie, D., Anderson, A.H., et al. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis 63 (2014), 236–243.
66. 66 Anderson, A.H., Yang, W., Hsu, C.Y., et al. Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis 60 (2012), 250–261.
67. 67 Harrell, F.E. Jr., Califf, R.M., Pryor, D.B., et al. Evaluating the yield of medical tests. JAMA 247 (1982), 2543–2546.
68. 68 Harrell, F.E. Jr., Lee, K.L., Mark, D.B., Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15 (1996), 361–387.
69. 69 Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int(suppl 3), 2013, 1–150.